Welcome

Device

Galpha has been an extended family of mine. People from diverse walk of life, culture & background have joined to form an integrated large family. It makes me happy to see that we are working together for a common cause to provide quality medicines to improve quality of life at an affordable price. With four divisions in operation, sales have significantly grow, and all of us are working together to make things better.

My team feels, the company belongs more to them and work with a spirit of belonging, to which I do agree happily. It is the collective strength of my people that makes me to feel strong. I extend all the support and assistance that they may require. I wish, Galpha all success and with its growth may all be benefited.

Shri N. K. Singh, CMD

Device

Fulfilling our commitments to our customers, is the foundation on which we have build up a strong & long term relationship with our customers & associates.

Quality of our products & individualized services are the corner stone of our progress. Having multiple state-of- the-art manufacturing units in different locations of India and an efficient and extensive distribution network both nationally & inter-nationally, has ensured quality of products and time bound delivery system. We don't compromise on these.

On the Export front, presently, we are well established in Africa, Eurasia, CIS, South East Asia And Central American region. Our immediate plan is to establish Galpha in Regulated markets through our Business Alliances. In the coming years we are planning to became a major player in International market including Europe, Africa, Asia and South America. To meet our Export objectives, we are already equipped with the required international standards in terms of technology, production capacity, infrastructure, regulatory affairs and validations. To be able to consistently fulfil the expectations of our Importers, one of our strength lies in our domestic success.

Galpha having crossed of 300 crore and growing at 45%, has emboldened us to look beyond the national horizon. With a Field Force of about 800 plus, operating from Kashmir to Kanyakumari, the entire length & breath of India is covered, visiting more than 7 million doctors every month. A wide range of 300 plus quality products comprising of various segments, 26 depots/C&Fs & Central Warehouses spread evenly across the country has helped us to gain confidence in understanding the requirements of the medical fraternity and the pharmaceutical business.

Our Institutional Division has registered a growth of 125%, and we feel proud to be doing business with some of the most esteemed organizations of India. Today, Galpha's name in the Institution sector is well known. Our business is continuously growing with government, semi-government & private organizations of the country. Quality of products, tailor made services and meeting deadlines has helped us to establish ourselves in this segment.

Presently, the list of high profile Organizations to which we supply exceeds more than 50. To name a few of them, 1. Employees State Insurance Corporation 2. Director of Health Services 3. Indian defence Services 4. Central Government Health Scheme 5. Steel Authority of India Limited 6. Coal India 7. Apollo Hospital.

Our branded Generic Division too is looked upon with respect for its high standard of quality products and services. With a range of more than 270 products for this division alone, we are able to meet the requirements of a wide range of customer's preferences. From Mega Metro Cities to deepest interiors, we make our products available throughout the country. As an acceptance of our high standard of Manufacturing Units, some of the respected pharmaceutical houses in India trust us in getting their products manufactured through us.

Dr.J.P.N.Singh, Director

Device

With Galphas growth as one of the fastest in the country, managing finance effectively is one of the key portfolios.

With rapid expansion in installing latest version of manufacturing units, upgrading machineries in existing units, purchase related to existing and new product launches, managing the budget, servicing the ODs all goes into a fine balancing act.

Of the many advantages that we have, confidence and faith of our bankers on us always stands in good stead. Our primary bankers, have been doing business with us for decades and are almost a part of us. Our in house, finance / accounts team is led by highly qualified and competent people, who well understand in which side of bread the butter is !

With various divisions doing well has helped us to keep the bottom line healthy.

Mrs.Rinu Sharma, Director

Device

We at Galpha is like a large family, with a balanced mix of experience and fresh energy. We have with us people serving for nearly thirty years, and at the same time new blood being infused, and I am one of them and happy to be here.

With so much happening around here and all at the same time; the pace and excitement is thrilling. Particularly, in the Marketing front, where regularly new molecules are launched, strategies are sharpened, sales graphs watched expectantly !

With export business increasing by the day, we are faced with new challenges. But, get our confidence and strength lies in our overseas buyers themselves, who have expressed their faith on us with repeat orders. The list of such customers too have been increasing. This has been of great motivation to us in Galpha.

With our domestic business of Ethical, Institution, Branded Generic, Manufacturing (job work) and Exports exceeding USD 15 million, we have the advantage of having our eggs spread in many baskets.

Mrs.Neha Singh, Director

Device

Galpha Laboratories started its manufacturing unit in Gujarat in Ankleshwar for oral liquid formulations, oral capsules and solids. At the same time we are carrying out contract manufacturing for Alkem to combine our oral capacity with their injectable line.

The flagship products of Galpha are multivitamin-multimineral formulations. We are also covering oral and injectable antibiotics. Galpha's growth percentage has been in the double digits, close to 22%. We are covering Africa, Southeast Asia, and Russia. Last year we entered the United States market and this year we entered the European market.

Drug delivery system that has played an important role in pharma growth. We have gone into pellets technology, because drugs in a ball roll faster within the body than flat substances. Galpha is now developing most of our products in pellet form.

In the domestic market we are adding one more division for general products. In exports we will be focusing more on regulated markets, and looking into semi-regulated markets. We want to do more business in Europe and the United States. We are focusing more on preventive medication and launching them in the United States.